abstract |
FIELD: medicine, chemical- pharmaceutical industry, pharmacy. SUBSTANCE: invention proposes sanguiritrin-base an antibacterial agent of the general resorptive effect as tablets covered by enterosoluble envelope. Sanguiritrine enterosoluble tablets are prescribed for children and adults by oral route for treatment of dysbacteriosis and intestinal infections (dysentery, salmonellosis, food toxic infections, acute infectious gastroenteritis, acute infectious enterocolitis) and in reconvalescent germ carrier accompanying different infectious inflammatory processes. Invention provides elimination of by-side effects (nausea, vomiting, diarrhea). EFFECT: enhanced effectiveness of drug. 15 cl, 6 ex |